Vermillion's Aspira Labs Wins Coverage from BCBS of Michigan for OVA1

Mar 02, 2017

NEW YORK (360Dx) – Vermillion said yesterday that Blue Cross Blue Shield (BCBS) of Michigan has agreed to cover its OVA1 ovarian cancer test.

BCBS of Michigan covers more than 6 million people in Michigan and the larger Great Lakes region.

Valerie Palmieri, president and CEO of Vermillion, said in a statement that the company continues to execute on its managed care strategy and that Michigan and the surrounding region are an area of focus for its commercialization efforts.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Main menu